Notes - Segment Information

Astellas Pharma Inc. - Filing #7540970

Concept As at
2023-09-30
2023-07-01 to
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
2022-07-01 to
2022-09-30
2022-04-01 to
2022-09-30
Notes - Segment information
Segment information
Revenue
Revenue
392,147,000,000 JPY
767,138,000,000 JPY
380,394,000,000 JPY
762,185,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
-923,000,000 JPY
-237,000,000 JPY
1,429,000,000 JPY
1,779,000,000 JPY
Profit (loss) before tax
5,328,000,000 JPY
52,178,000,000 JPY
88,801,000,000 JPY
120,480,000,000 JPY
Assets
3,543,021,000,000 JPY
2,456,518,000,000 JPY
Investments accounted for using equity method
15,344,000,000 JPY
12,689,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.